Clinical Trials on Acne Vulgaris

Total 1065 results

Dermira, Inc.

Completed

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Acne Vulgaris

United States, Canada, Australia
YUN NV
Allergisa Pesquisa Dermato-Cosmetica LTDA

Completed

Skin Acceptance and Efficacy Assessment of a Topical Product in Acne Treatment When Compared to a Placebo.

Acne Vulgaris

Brazil
Gage Development Company, LLC

Completed

Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Dr. Reddy's Laboratories Limited

Completed

A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%

Acne Vulgaris

United States
Galderma R&D
Proinnovera GmbH

Completed

Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris (Benzac)

Acne Vulgaris

Germany
Galderma R&D

Completed

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

Acne Vulgaris

United States, Canada
Vyne Therapeutics Inc.

Completed

A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.

Acne Vulgaris

United States
Istanbul Medeniyet University

Unknown

Social Media Use of Acne Vulgaris Patients: Multicenter, Survey Work

Acne Vulgaris

Turkey
Istanbul Medeniyet University

Completed

Use of Alternative Therapy in Acne Vulgaris Patients

Acne Vulgaris

Turkey
Integrative Skin Science and Research
Microbiome labs

Unknown

Oral Probiotics on the Microbiome and Lipidome in Acne Vulgaris

Acne Vulgaris

United States
Zydus Lifesciences Limited

Completed

To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel

Acne Vulgaris

United States, India
Actavis Inc.

Completed

A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris

Acne Vulgaris

United States, Belize
Almirall, S.A.
Allergan

Completed

Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris

Acne Vulgaris

Canada, United States, Germany, Hungary, Puerto Rico
Taro Pharmaceuticals USA

Completed

Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Sol-Gel Technologies, Ltd.
Accelovance

Completed

Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris

Acne Vulgaris

United States
University of California, Los Angeles
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

"Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"

Acne Vulgaris

United States
Assiut University

Unknown

Sexual Dysfunction in Female Patients With Adult Acne Vulgaris

Acne Vulgaris
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne

Acne Vulgaris

United States
Xenon Pharmaceuticals Inc.

Completed

A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel

Acne Vulgaris

Canada
Novan, Inc.

Completed

A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel

Acne Vulgaris

United States
Taro Pharmaceuticals USA

Completed

Efficacy Study in Patients With Acne Vulgaris.

Acne Vulgaris
Novan, Inc.
WCCT Global

Completed

Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris

Acne Vulgaris

United States
Wake Forest University
Galderma R&D

Completed

Effect of Samples on Acne Treatment With Epiduo® Gel

Acne Vulgaris

United States
Wake Forest University

Completed

Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne

Acne Vulgaris

United States
Rumah Sakit Pusat Angkatan Darat Gatot Soebroto

Completed

Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia

Acne Vulgaris
Galderma R&D

Completed

Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris

Acne Vulgaris

United States, Canada
Taro Pharmaceuticals USA

Completed

To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Northwestern University

Completed

Cultural Differences in Treatment Preferences and Perceptions of Acne (CDTPPA)

Acne Vulgaris

United States
GlaxoSmithKline

Completed

Japanese Phase 1 Study of GSK2585823 (JPN P1)

Acne Vulgaris

Japan
GlaxoSmithKline

Completed

A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris

Acne Vulgaris

Japan
Stiefel, a GSK Company
GlaxoSmithKline

Completed

W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne

Acne Vulgaris

United States
Taro Pharmaceuticals USA

Completed

Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Thesan Pharmaceuticals, Inc.

Withdrawn

TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Dominican Republic, Honduras
BioPharmX, Inc.

Completed

BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris (OPAL)

Acne Vulgaris

United States
Bayer
RTI Health Solutions

Completed

Risk Minimisation Study for Diane-35 and Its Generics

Acne Vulgaris

France, Spain, Austria, Czech Republic, Netherlands
Bayer

Completed

Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases

Acne Vulgaris

United Kingdom, Italy, Netherlands
AOBiome LLC

Completed

A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris.

Acne Vulgaris

Japan
Seegpharm S.A.

Completed

Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Belize

3

Subscribe